The Nigeria Customs Service (NCS) has intercepted a major smuggling attempt involving a large consignment of unregistered pharmaceutical products bearing falsified NAFDAC registration numbers.
​The illicit cargo was uncovered during a routine cargo examination by eagle-eyed customs officers, who noticed discrepancies in the clearance documentation. Upon closer inspection and verification with the National Agency for Food and Drug Administration and Control (NAFDAC) database, the registration number printed on the packaging was discovered to be entirely fraudulent.
​According to preliminary reports from the NCS, the smugglers utilized the fake regulatory numbers in a deliberate attempt to bypass stringent border checks and deceive field officers. The intercepted shipment contained a variety of unregulated antibiotics, analgesics, and other high-risk medications that pose severe public health threats.
​The Customs Area Controller in charge of the operation emphasized that the successful interception prevented potentially lethal, unverified chemicals from flooding the Nigerian market.
​”This is not just economic sabotage; it is a direct assault on the lives of Nigerians,” the Comptroller stated. “The offenders went to great lengths to clone NAFDAC identifiers, proving that these syndicates are becoming more sophisticated. However, our collaboration with sister agencies ensures we remain a step ahead.”
​The seized pharmaceuticals have been impounded, and officials confirm that investigations are underway to track down the importers, clearing agents, and shipping companies involved in the logistical chain.
​The NCS reiterated its commitment to tightening security at all entry points—seaports, airports, and land borders. In the coming days, the confiscated goods are expected to be officially handed over to NAFDAC for destruction and further legal action against the perpetrators.
​Members of the public are urged to remain vigilant and purchase medications only from registered, reputable pharmacies while reporting suspicious pharmaceutical distribution channels to the appropriate authorities.
